bexarotene has been researched along with Allodynia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Guden, DS; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz-Resitoglu, M; Tunctan, B | 1 |
1 other study(ies) available for bexarotene and Allodynia
Article | Year |
---|---|
Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Bexarotene; Cyclooxygenase 2; Hyperalgesia; Lipopolysaccharides; Male; MAP Kinase Kinase Kinases; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-kappa B p50 Subunit; Retinoid X Receptors; Signal Transduction; Toll-Like Receptor 4 | 2021 |